Form 8-K - Current report:
SEC Accession No. 0001193125-24-233794
Filing Date
2024-10-07
Accepted
2024-10-07 16:10:55
Documents
14
Period of Report
2024-10-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d787897d8k.htm   iXBRL 8-K 28100
  Complete submission text file 0001193125-24-233794.txt   187008

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nuvb-20241007.xsd EX-101.SCH 3878
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nuvb-20241007_def.xml EX-101.DEF 13656
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvb-20241007_lab.xml EX-101.LAB 22575
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvb-20241007_pre.xml EX-101.PRE 14624
16 EXTRACTED XBRL INSTANCE DOCUMENT d787897d8k_htm.xml XML 5700
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

EIN.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39351 | Film No.: 241357954
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)